Harvard Bioscience, Inc. (HBIO)
Largest Insider Buys in Sector
HBIO Stock Price History Chart
HBIO Stock Performance
About Harvard Bioscience, Inc.
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ-based lab research, including surgical products, infusion systems, and behavior research systems; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation and electrofusion instruments. It also engages in the development and manufacture of precision scientific measuring instrumentation and equipment, which cover data acquisition systems with custom amplifier configurations for cellular analysis, micro electrode array solutions for in vivo recordings, and vitro-systems for extracellular recordings; and offers preclinical products. The company markets its products through sales organizations, websites, catalogs, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories, as well as to contract research organizations, academic labs, and government researchers. It primarily sells its products under Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS brand names. The company was founded in 1901 and is headquartered in Holliston, Massachusetts.
Insider Activity of Harvard Bioscience, Inc.
Over the last 12 months, insiders at Harvard Bioscience, Inc. have bought $200,000 and sold $0 worth of Harvard Bioscience, Inc. stock.
On average, over the past 5 years, insiders at Harvard Bioscience, Inc. have bought $333,991 and sold $582,106 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Green James W (Chief Executive Officer) — $400,000.
The last purchase of 10,000 shares for transaction amount of $29,100 was made by Green James W (Chief Executive Officer) on 2024‑06‑13.
List of Insider Buy and Sell Transactions, Harvard Bioscience, Inc.
| 2024-06-13 | Green James W | Chief Executive Officer | 10,000 0.0242% | $2.91 | $29,100 | -0.34% | ||
| 2024-06-06 | Green James W | Chief Executive Officer | 20,000 0.0474% | $3.07 | $61,400 | -2.52% | ||
| 2023-08-17 | Green James W | Chief Executive Officer | 25,000 0.06% | $4.38 | $109,500 | -1.15% | ||
| 2023-03-15 | Green James W | Chief Executive Officer | 20,000 0.0468% | $2.60 | $52,000 | +71.21% | ||
| 2023-03-15 | EDRICK ALAN I | director | 16,192 0.0382% | $2.62 | $42,423 | +71.21% | ||
| 2023-03-14 | Green James W | Chief Executive Officer | 20,000 0.0475% | $2.67 | $53,400 | +69.29% | ||
| 2023-03-14 | EDRICK ALAN I | director | 13,808 0.0328% | $2.67 | $36,867 | +69.29% | ||
| 2022-12-01 | Green James W | Chief Executive Officer | 15,000 0.0341% | $2.61 | $39,150 | +54.15% | ||
| 2022-11-30 | Green James W | Chief Executive Officer | 15,000 0.0341% | $2.41 | $36,150 | +66.60% | ||
| 2022-08-26 | LOY BERTRAND | 9,291 0.0231% | $3.41 | $31,682 | -5.78% | |||
| 2022-08-24 | LOY BERTRAND | 8,244 0.0207% | $3.34 | $27,535 | -2.82% | |||
| 2022-08-22 | LOY BERTRAND | 4,918 0.0118% | $3.16 | $15,541 | -2.21% | |||
| 2022-08-18 | LOY BERTRAND | 1,151 0.0028% | $3.19 | $3,672 | -2.52% | |||
| 2022-08-17 | Green James W | Chief Executive Officer | 40,000 0.0961% | $3.19 | $127,600 | -2.82% | ||
| 2022-06-15 | Green James W | Chief Executive Officer | 30,000 0.0734% | $3.71 | $111,300 | -15.53% | ||
| 2022-05-06 | Green James W | Chief Executive Officer | 10,000 0.0219% | $3.40 | $34,000 | -17.55% | ||
| 2021-08-23 | Sale | Green James W | Chief Executive Officer | 48,175 0.1175% | $8.02 | $386,364 | -26.02% | |
| 2021-05-21 | Sale | Green James W | Chief Executive Officer | 24,312 0.0605% | $7.14 | $173,588 | -2.52% | |
| 2021-05-20 | Sale | Green James W | Chief Executive Officer | 14,876 0.0372% | $7.03 | $104,578 | -0.43% | |
| 2021-05-18 | Sale | Green James W | Chief Executive Officer | 39,188 0.0988% | $7.41 | $290,383 | -4.37% |
Insider Historical Profitability
| Green James W | Chief Executive Officer | 3111091 6.706% | $2.89 | 16 | 5 | +24.69% |
| Skystone Advisors LLC | 10 percent owner | 3744819 8.7725% | $2.89 | 64 | 5 | +9.98% |
| GRAZIANO CHANE | 10 percent owner | 3105150 7.274% | $2.89 | 5 | 0 | +21.41% |
| HSO LIMITED PARTNERSHIP | 10 percent owner | 2757257 6.4591% | $2.89 | 40 | 2 | +8.24% |
| GREEN DAVID | director | 925571 2.1682% | $2.89 | 15 | 73 | +46.82% |
| Duchemin Jeffrey | Chief Executive Officer | 830888 1.9464% | $2.89 | 4 | 12 | +3.29% |
| LEWIS EARL R | director | 467350 1.0948% | $2.89 | 9 | 1 | +28.78% |
| LOY BERTRAND | 399651 0.9362% | $2.89 | 11 | 0 | +3.36% | |
| Gagnon Robert E. | Chief Financial Officer | 321169 0.7524% | $2.89 | 6 | 12 | +16.32% |
| EDRICK ALAN I | director | 202485 0.4743% | $2.89 | 3 | 0 | +66.06% |
| KENNEDY JOHN F | director | 177330 0.4154% | $2.89 | 2 | 0 | <0.0001% |
| UVEGES GEORGE | director | 142685 0.3342% | $2.89 | 5 | 2 | +13.68% |
| Eade Katherine A. | director | 121515 0.2847% | $2.89 | 1 | 0 | +15.32% |
| Loewald Thomas W | director | 103200 0.2418% | $2.89 | 1 | 0 | +15.6% |
| HARTE NEAL J | director | 25258 0.0592% | $2.89 | 0 | 1 |
Institutional Investor Ownership
| B Riley Asset Management Llc | $12.02M | 6.53 | 2.83M | -3.55% | -$442,388.89 | 4.82 | |
| BlackRock | $12.01M | 6.53 | 2.83M | -2.75% | -$339,836.02 | <0.0001 | |
| Punch & Associates Investment Management, Inc. | $11.75M | 6.38 | 2.77M | -4.99% | -$617,746.78 | 0.68 | |
| Harvey Partners | $10.84M | 5.89 | 2.56M | 0% | +$0 | 1.18 | |
| Amh Equity Ltd | $9.85M | 5.35 | 2.32M | +7.46% | +$683,941.68 | 12.33 | |
| The Vanguard Group | $9.13M | 4.96 | 2.15M | +2.36% | +$210,202.26 | <0.0001 | |
| Dimensional Fund Advisors | $8.17M | 4.44 | 1.93M | +0.04% | +$2,929.84 | <0.01 | |
| Granahan Investment Management | $7.9M | 4.29 | 1.86M | +1.1% | +$85,927.84 | 0.28 | |
| ROYCE & ASSOCIATES INC | $5.72M | 3.11 | 1.35M | -7.03% | -$432,692.00 | 0.05 | |
| Boothbay Fund Management LLC | $5.7M | 3.1 | 1.34M | -1.3% | -$75,094.64 | 0.19 | |
| Acadian Asset Management | $4.25M | 2.31 | 1M | -0.57% | -$24,379.13 | 0.02 | |
| Heartland Advisors Inc | $3.77M | 2.05 | 889,133 | +2.62% | +$96,103.84 | 0.03 | |
| Geode Capital Management | $3.63M | 1.97 | 856,224 | +6.41% | +$218,758.92 | <0.0001 | |
| Meros Investment Management Lp | $3.48M | 1.89 | 821,792 | +0.25% | +$8,658.08 | 1.56 | |
| Renaissance Technologies | $2.98M | 1.62 | 702,478 | -2.48% | -$75,908.57 | 0.01 | |
| Portolan Capital Management | $2.96M | 1.61 | 697,840 | +3.82% | +$108,840.82 | 0.23 | |
| State Street | $2.94M | 1.6 | 693,229 | +1.58% | +$45,817.44 | <0.0001 | |
| Northern Trust | $1.93M | 1.05 | 456,097 | -2.47% | -$48,976.23 | <0.0001 | |
| Acuitas Investments, LLC | $1.38M | 0.75 | 326,516 | 0% | +$0 | 0.73 | |
| Kennedy Capital Management Inc | $1.36M | 0.74 | 321,523 | -1.46% | -$20,190.89 | 0.03 | |
| Bard Associates, Inc. | $1.24M | 0.67 | 291,320 | +2.07% | +$25,007.52 | 0.46 | |
| Archon Capital Management Llc | $1.11M | 0.6 | 260,858 | -6.62% | -$78,440.01 | 0.02 | |
| BNY Mellon | $1.03M | 0.56 | 243,130 | -2.6% | -$27,479.44 | <0.0001 | |
| Charles Schwab | $974,263.00 | 0.53 | 229,779 | -2.92% | -$29,247.52 | <0.0001 | |
| Greenwood Capital | $918,443.00 | 0.5 | 216,614 | -1.81% | -$16,913.35 | 0.12 | |
| Bridgeway Capital Management | $782,280.00 | 0.43 | 184,500 | -7.01% | -$58,936.00 | 0.02 | |
| New York State Common Retirement Fund | $756,000.00 | 0.41 | 178,350 | +25.19% | +$152,132.55 | <0.01 | |
| Pasadena Private Wealth Llc | $731,336.00 | 0.4 | 172,485 | 0% | +$0 | 0.18 | |
| GlobeFlex Capital | $626,680.00 | 0.34 | 147,802 | -6.28% | -$42,022.61 | 0.06 | |
| Connor Clark & Lunn Investment Management Ltd | $610,793.00 | 0.33 | 144,055 | +1.81% | +$10,879.84 | <0.01 | |
| Nuveen | $593,596.00 | 0.32 | 139,999 | 0% | +$0 | <0.0001 | |
| Ohio Strs | $488,000.00 | 0.27 | 115,200 | +9.92% | +$44,055.56 | <0.01 | |
| ClariVest Asset Management LLC | $470,805.00 | 0.26 | 111,039 | +0.19% | +$881.92 | 0.05 | |
| Riverwater Partners | $395,155.00 | 0.22 | 93,197 | +14.06% | +$48,726.04 | 0.32 | |
| Two Sigma Advisers LP | $373,781.00 | 0.2 | 88,156 | -16.25% | -$72,503.91 | <0.01 | |
| Morgan Stanley | $339,264.00 | 0.18 | 80,015 | -26.98% | -$125,355.75 | <0.0001 | |
| Assenagon Asset Management S.A. | $328,528.00 | 0.18 | 77,483 | 0% | +$0 | <0.01 | |
| Prudential Financial | $308,926.00 | 0.17 | 72,860 | -18.65% | -$70,807.91 | <0.0001 | |
| Jacobs Levy Equity Management | $273,802.00 | 0.15 | 64,576 | -4.34% | -$12,435.91 | <0.01 | |
| Winton Capital Management | $271,534.00 | 0.15 | 64,041 | -0.15% | -$407.04 | 0.02 | |
| Invesco | $243,075.00 | 0.13 | 57,329 | +24.64% | +$48,047.69 | <0.0001 | |
| Two Sigma | $177,999.00 | 0.1 | 41,981 | -21.15% | -$47,733.80 | <0.0001 | |
| UBS | $172,692.00 | 0.09 | 40,729 | -12.55% | -$24,782.95 | <0.0001 | |
| Goldman Sachs | $169,303.00 | 0.09 | 39,930 | -0.85% | -$1,458.56 | <0.0001 | |
| RhumbLine Advisers | $162,135.00 | 0.09 | 38,241 | +4.54% | +$7,042.34 | <0.0001 | |
| Legato Capital Management Llc | $148,519.00 | 0.08 | 35,028 | +9.4% | +$12,766.66 | 0.02 | |
| Barclays | $121,000.00 | 0.07 | 28,657 | -48.64% | -$114,598.91 | <0.0001 | |
| Hillsdale Investment Management Inc. | $111,936.00 | 0.06 | 26,400 | New | +$111,936.00 | 0.01 | |
| Advisor Group Holdings Inc | $107,435.00 | 0.06 | 25,340 | +25,240% | +$107,011.03 | <0.0001 | |
| Deutsche Bank | $96,519.00 | 0.05 | 22,764 | +2.84% | +$2,662.71 | <0.0001 |